Pain after Cardiac surgery by median sternotomy
Conditions
Interventions
Group 1: The treatment group will receive an echo-guided parasternal block using Ropivacaine 2 mg/mL, 40 mL at the end of surgery.
Group 2: The placebo group will receive an echo-guided parasternal bl
Sponsors
H.U.B - Hôpital Erasme
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Cardiac surgery by median sternotomy Age > 18 years Informed written consent
Exclusion criteria
Exclusion criteria: Known allergy to ropivacaine renal insufficiency, defined as a glomerular filtration rate < 30 mL/min/1.73 m2 Hepatic insufficiency, Class Child-Pugh C Left ventricular ejection fraction < 40% Weight < 40 kg Chronic use of opioids Pregnancy Breast feeding Emergency surgery Surgical reoperation during the first 24 hours Dementia or any psychiatric disease Inability to use a patient-controlled analgesia device
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary Outcome Measure: Morphine consumption All patients will receive intravenous morphine first by manual IV administration until adequate analgesia is reached, then by patient-controlled analgesia. Total morphine consumption over the first 24 hours will be recorded. [Time Frame: 24 hours] | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary Outcome Measures: Incidence of nausea or vomiting The incidence of nausea and vomiting (% of patients) in the first 24 postoperative hours will be recorded [Time Frame: 24 hours] | — |
Countries
Belgium
Contacts
Public ContactLaurent Perrin
H.U.B - Hôpital Erasme
Outcome results
None listed